局所性前立腺がん患者の併発症と治療後悔の関連 - 集団ベースのコホートからの結果
Rahul D Mali1, Ying Cao1, Aaron J Katz2
1Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Practical radiation oncology
|September 1, 2025
まとめ
前立腺がんと健康上の問題を抱えた男性は,治療後に決断を後悔することが多いと報告しています. 併発性疾患の対処は 治療の選択に不可欠です
科学分野:
- 腫瘍学
- 泌尿器科
- 医療サービス研究
背景:
- 前立腺がん治療の後に起こる 決定後悔は重大な悪影響です
- 併発症は治療の耐受性に影響し,患者の満足度にも影響を及ぼす可能性があります.
研究 の 目的:
- 前立腺がん患者における併発症負担と決定後悔の関連性を調査する.
- 局所性前立腺がん治療後の決定後悔に関連する要因を特定する.
主な方法:
- 981人の前立腺がん患者を対象とした前向きな集団研究.
- 治療後12ヶ月で評価された患者による後悔.
- 併発症はNCI併発症指数を用いてスコア付けされ,分析には多変数ロジスティック回帰が用いられました.
主要な成果:
- 患者の11%が決定を後悔したと報告した.
- 併発症の負担が大きい (OR1. 58),結婚していない (OR1. 72),腸 (OR2.12) または尿道症状の悪化 (OR1. 60) が後悔と関連していました.
- 放射線治療は,急性前立腺切除手術 (OR0. 48) よりも後悔の少ない結果と関連していました.
結論:
- 局所性前立腺がんにおける決定後悔の増加の有意な予測因子である.
- 併発性疾患の評価は 情報に基づいた意思決定と 患者の期待管理に不可欠です
- 併発症の負担を考慮すると,よりパーソナライズされ,満足のいく治療結果が得られます.
関連する概念動画
01:20Disorders of the Male Reproductive System
570
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
570
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:21Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
112
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
112
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174